GGrantIndex
Sort

40,608 grants matching prostate cancer

AZI1 RNA-DRIVEN GENE FUSION IN PROSTATE CANCER

$1,200,000
Baylor College Of Medicine · · FY2020 · Defense Health Agency

SCH: Edge AI for a Bioimpedance System-on-Chip

$1,199,999
Kofi Odame · Dartmouth College · · FY2024 · CSE

Novel Small-Molecule Inhibitors of Bcl-2/Bcl-xL Protein*

$1,199,944
University Of Michigan At Ann Arbor · U19 · FY2005 · CA

Signal Transduction Events and the Regulation of Cell Growth

$1,199,893
Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2021 · CA

Modeling Precision Interventions for Prostate Cancer Control

$1,199,654
Ruth D Etzioni · Fred Hutchinson Cancer Center · U01 · FY2024 · CA

Animal Model and Genotyping Core Support Facility

$1,199,640
Wendy Du Bois De Vroylande · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA

ROLE OF E3E3 UBIQUITIN LIGASE TRIM25 IN PROSTATE CANCER.

$1,199,583
Emory University · · FY2021 · Defense Health Agency

Novel Molecular Therapies of Prostate Cancer

$1,199,386
Dario C. Altieri · Wistar Institute · P01 · FY2011 · CA

PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate BiomarkersTask Order Title: Sulforaphane for the Prevention of Malignant Mesothelioma

$1,199,274
Joseph Testa · Research Inst Of Fox Chase Can Ctr · N01 · FY2023 · CA

HIGH INTRAPROSTATIC ANDROGENS IN AFRICAN AMERICAN MEN PRIMES FOR AGGRESSIVE PROSTATE CANCER

$1,199,250
University Of Illinois · · FY2020 · Defense Health Agency

MAPPING INTERACTIVE CANCER SUSCEPTIBILITY LOCI

$1,198,914
City Of Hope/Beckman Research Institute · R01 · FY2001 · AG

Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG

$1,198,721
Arkadij Elizarov · Trace-Ability, Inc. · R44 · FY2018 · CA

EVALUATING DISPARITIES AND IMPROVING QUALITY OF PROSTATE CANCER DETECTION FOR VETERANS THROUGH IMAGING

$1,198,659
Northwestern University · · FY2025 · Defense Health Agency

PROSTATE CANCER CLINICAL TRIALS CONSORTIUM CLINICAL RESEARCH SITE: UNIVERSITY OF WASHINGTON

$1,197,864
University Of Washington · · FY2017 · Defense Health Agency

Novel Molecular Therapies of Prostate Cancer

$1,197,703
Dario C. Altieri · Wistar Institute · P01 · FY2014 · CA

Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI

$1,197,259
Gregory John Metzger · University Of Minnesota · R01 · FY2025 · CA

Center of Excellence in Eliminating Disparities

$1,197,220
Elizabeth Ann Calhoun · University Of Illinois At Chicago · P60 · FY2011 · MD

2/3 Morehouse School of Medicine/Tuskegee University/ University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

$1,197,000
Clayton Yates · Tuskegee University · U54 · FY2022 · CA

2/3 Morehouse School of Medicine/Tuskegee University/ University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

$1,197,000
Timothy Turner · Tuskegee University · U54 · FY2023 · CA

Clinical and Informatics Research on Large Clinical Databases

$1,196,486
Clement McDonald · National Library Of Medicine · ZIA · FY2025 · LM

Phase I and II Clinicla Trials of Cancer Prevention Agents

$1,196,000
Sherry Chow · University Of Arizona · N01 · FY2011 · CA

CHARACTERIZATION OF EARLY STAGE PROSTATE CANCER

$1,194,334
Sidney Kimmel Cancer Center · U01 · FY2001 · CA

Mouse Model of Cell Cycle Deregulation in Cancer

$1,193,552
University Of Texas Md Anderson Can Ctr · U01 · FY2003 · ES

Aspirin/Folate Prevention of Large Bowel Polyps

$1,193,416
John Anthony Baron · Univ Of North Carolina Chapel Hill · R01 · FY2011 · CA

CIP Genomics Core

$1,193,382
Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA